NCT07288203
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07288203
Title A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Iovance Biotherapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | CAN | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Greenslopes Private Hospital Greenslopes Queensland 4120 Australia Details
Princess Margaret Cancer Centre Toronto Ontario, Canada M5G 2M9 Canada Details
Centre Hospitalier de l'Universite de Montreal Montral Quebec, Canada H2X 0A9 Canada Details
Royal Marsden Hospital London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field